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Abstract
Transgenic rodents expressing Cre recombinase cell specifically are used for exploring mechanisms regulating behavior,
including those mediated by cholinergic signaling. However, it was recently reported that transgenic mice overexpressing
a bacterial artificial chromosome containing choline acetyltransferase (ChAT) gene, for synthesizing the neurotransmitter
acetylcholine, present with multiple vesicular acetylcholine transporter (VAChT) gene copies, resulting in altered cholinergic tone and accompanying behavioral abnormalities. Since ChAT::Cre+ rats, used increasingly for understanding the
biological basis of CNS disorders, utilize the mouse ChAT promotor to control Cre recombinase expression, we assessed
for similar genotypical and phenotypical differences in such rats compared to wild-type siblings. The rats were assessed for
mouse VAChT copy number, VAChT protein expression levels and for sustained attention, response control and anxiety. Rats
were also subjected to a contextual fear conditioning paradigm using an unconditional fear-inducing stimulus (electrical foot
shocks), with blood samples taken at baseline, the fear acquisition phase and retention testing, for measuring blood plasma
markers of hypothalamic–pituitary–adrenal gland (HPA)-axis activity. ChAT::Cre+ rats expressed multiple mouse VAChT
gene copies, resulting in significantly higher VAChT protein expression, revealed anxiolytic behavior, hyperlocomotion and
deficits in tasks requiring sustained attention. The HPA-axis was intact, with unaltered circulatory levels of acute stressinduced corticosterone, leptin and glucose. Our findings, therefore, reveal that in ChAT::Cre+ rats, VAChT overexpression
associates with significant alterations of certain cognitive, motor and affective functions. Although highly useful as an
experimental tool, it is essential to consider the potential effects of altered cholinergic transmission on baseline behavior in
ChAT::Cre rats.
Keywords ChAT::Cre rats · Cre-recombinase · 5-CSRTT· HPA endocrine axis · Touchscreen-based behavioral testing ·
Vesicular acetylcholine transporter
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BAC	Bacterial artificial chromosome
BSA	Bovine serum albumin
5-CSRTT	Five-choice serial reaction time task
ChR2	Channelrhodopsin-2
ChAT	Choline acetyltransferase
CFCT	Contextual fear conditioning task
DREADD	Designer receptors exclusively activated by
designer drugs
DAT	Dopamine transporter
EPM	Elevated plus maze
eYFP	Enhanced yellow fluorescent protein
EtOH	Ethanol
CHT1	High-affinity choline transporter
HSD	Honestly significant difference
HPA	Hypothalamic–pituitary–adrenal
ITI	Intertrial interval
LSD	Least significant difference
LDB	Light/dark box
LH	Limited hold
NS	Non-significant
NBMc	Nucleus basalis magnocellularis
NBM	Nucleus basalis of Meynert
OF	Open field
PD	Parkinson’s disease
PPN	Pedunculopontine nucleus
PCR	Polymerase chain reaction
PVDF	Polyvinylidene difluoride
PFC	Prefrontal cortex
qPCR	Quantitative PCR
RIPA	Radioimmunoprecipitation assay
RT-PCR	Real-time PCR
RRID	Research resource identifier
RT	Room temperature
SLC5A7	Solute carrier family 5 member 7
SD	Stimulus duration
TBS-T	Tris-buffered saline-Tween 20
TH	Tyrosine hydroxylase
VAChT	Vesicular acetylcholine transporter
Wt.	Wild-type

Introduction
Central cholinergic signaling is required for regulating
aspects of memory, motivation and mood. On the other
hand, cholinergic deficiency contributes to the neuropsychiatric symptoms associated with Alzheimer’s disease
(AD), with cholinomimetic therapies that may ameliorate
such symptoms (Felder et al. 2018). In addition, although
the main motor deficits characterizing Parkinson’s disease
(PD) patients stem from the near total loss of midbrain dopaminergic neurons, the concomitant loss and/or dysfunction
of cholinergic neurons is believed to underlie such patients’
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cognitive decline (Perez-Lloret and Barrantes 2016; Bury
et al. 2017). Hyperactivity of brain cholinergic systems could
also underlie the cognitive disturbances observed in patients
with affective disorders (Saricicek et al. 2012; Mineur et al.
2013), while additional evidence for this derives from clinical and preclinical studies which revealed that cholinergic
receptor blockers can induce antidepressant-like responses
(Furey and Drevets 2006). Furthermore, increasing data
from clinical pharmacology, neuroimaging and postmortem
studies implicates the cholinergic system in the pathogenesis
of schizophrenia (Sarter et al. 2012). Conversely, growing
evidence suggest that pharmacologically increasing cholinergic signaling could improve several symptom clusters,
including visual hallucinations, in schizophrenia patients
(Foster et al. 2012). However, despite the accumulating
evidence in support of cholinergic perturbations as an etiological factor in several neuropsychiatric human diseases,
patients remain mostly unresponsive to current cholinergicbased pharmacological therapies. This highlights a need for
establishing appropriate mammalian models for understanding the cholinergic roots of these disorders and for in vivo
validation of candidate therapeutics that are potentially more
effective treatments, by specifically correcting the relevant
pathophysiological mechanisms.
For modeling human disease, rats offer several distinct
advantages over mice and other organisms. Benefits include
increased spatial resolution due to rats’ larger sized heads,
which provides practical advantages for performing surgical procedures, including intracerebral cannula implantation
for localized drug infusion into a specific brain region, to
determine the role of this region in a particular behavioral
phenotype (Kokare et al. 2011). Proportionally, larger brain
substructure sizes also lends itself to more precise implantation of microdialysis probes for sampling neurotransmitter
concentrations, as the cannula causes less damage by affecting smaller regions. Although mice continue to offer distinct
advantages over rats for precise targeting of gene expression to defined neuronal populations (Taniguchi et al. 2011;
Madisen et al. 2012; Gerfen et al. 2013), tremendous strides
made in developing a toolbox of transgenic rat lines have
allowed for unprecedented interrogation of cell type-specific
neural populations and -circuits. Such experimental strides
are permitted by engineering cell-specific targeting in a Cre
recombinase-dependent manner, along with advances made
in engineered viral vectors. These transgenic rat technologies can be combined with opsin- and Designer Receptors
Exclusively Activated by Designer Drugs (DREADDs), for
untangling the neural substrates of a wide plethora of behaviors; these are beginning to be tapped in research studies
(e.g., Sharma and Pienaar 2014, 2018).
Choline acetyltransferase (ChAT)::Cre+ transgenic rats,
utilizing bacterial artificial chromosome (BAC) recombineering for introducing a transgene of interest under control of
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cholinergic neuronal-specific promoter elements (Witten et al.
2011) were generated to genetically restrict expression of Cre
recombinase in cholinergic neurons. As an additional genetic
element, the BAC is inserted within the genome, sometimes
in multiple copies, with the original ChAT locus that remains
intact.
Such rats are extremely useful in promoting understanding of cholinergic circuits (Aldrin-Kirk et al. 2018; Dautan
et al. 2014, 2016; Gielow and Záborszky 2017) including their
role in motor function and reward-related behaviors during
both homeostatic and disease processes (Pienaar et al. 2015;
Dautan et al. 2016; Xiao et al. 2016). The generation of these
transgenic rats followed on from work using transgenic mice
was designed to encode channelrhodopsin-2 (ChR2) protein
under the control of the ChAT promoter (Heintz 2001). This
design largely ignores the tandem gene arrangement for the
cholinergic gene locus (Prado et al. 2017), where the gene
for the vesicular acetylcholine transporter is nested within the
first intron of the ChAT gene. Evidence is accumulating that in
ChAT::Cre+ rodents, altered expression of the gene encoding
for the vesicular acetylcholine transporter (VAChT), which
serves as a key molecular component of acetylcholine (ACh)
release by loading ACh molecules into the synaptic vesicles
of cholinergic synapses, could modify baseline cholinergic
tone. This modification could provide a mechanistic basis for
changing aspects such as locomotion, operant conditioning,
spatial and working memory, attention, as well as intravenous
nicotine self-administration behaviors, as had been reported for
ChAT-ChR2-eYFP BAC transgenic mice, compared to wildtype (Wt/Wt) and hemizygous (Tg/Wt) littermates (Kolisnyk
et al. 2013; Sugita et al. 2016; Chen et al. 2018; Janickova
et al. 2017).
Here, we determined the mRNA and protein expression levels of VAChT in ChAT::Cre+ rats compared to Wt
(ChAT::Cre−) ones, to gain mechanistic understanding as to
the influence exerted by altered expression of cholinergic signaling factors in performance in the five-choice serial reaction
time task (5-CSRTT), a well-validated measure of attention
and impulsivity (Robbins 2002). We further conducted motor
and anxiety profiling in the transgenic rats compared to their
Wt littermates, using a range of well-validated behavior tests.
Due to compelling evidence that the cholinergic system plays a
role in stress and, specifically in hypothalamic–pituitary–adrenal gland (HPA)-axis activation and regulation, we also determined whether ChAT::Cre+ rats manifest a dysregulation of
this endocrine control system (Paul et al. 2015).
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Materials and methods
Animals
The animal experiments were approved by an ethics panel
at Northumbria University (Ref: BMS39UNNGB2015)
and were performed in accordance with the Animals (Scientific Procedures) Act, 1986 (UK) for the care and use
of experimental animals as well as the European Communities Council Directive (2010/63/EEC). All rats were
examined weekly by a veterinarian and constantly monitored by experienced animal technicians for signs of pain
or distress. Long-Evans Wt rats [Charles River, Kent, UK;
Research Resource Identifier (RRID): RGD_2308852]
were bred with hemizygous Long-Evans ChAT::Cre rats
(Missouri Mutant Mouse Regional Resource Centre,
University of Missouri, USA; RRID: RGD_10401204);
both providers supplied up-to-date authentication reports.
Once weaned, ear clippings were taken from each pup
and analyzed for the Cre recombinase gene using polymerase chain reaction (PCR). The primers used were as
described by Witten et al. (2011) and consisted of AAG
AACCTGATGGACATGTTCAGGGATCG (forward) and
CCACCGTCAGTACGTGAGATATCTTTAACC (reverse),
which produced a positive band corresponding to 600 base
pairs. The PCR cycling conditions were similar to those
described by Witten et al. (2011).
Only mature male rats (weight: 270–310 g) were used
in the experiments to minimize gender and hormonal influences on behavior (Keeley et al. 2015). As an additional
control condition for analyzing mouse VAChT gene copy
number, brain tissue was also collected from male littermate Wt control mice (weight: 25–30 g, on the C57BL/6
background, received from Charles River, UK).
Animals were housed in groups of 3–4 per cage in polypropylene cages measuring 56 × 38 × 22 cm (RC2F; North
Kent Plastics Cages, Coalville, UK) within an animal care
facility at the University of Cambridge, in a temperature
(23 °C) and humidity (45–65%) controlled room with
a reversed light/dark cycle (lights off between 7:00 and
19:00 h). The behavioral experiments were carried out at
the same time each day, during the dark period which represents the rats’ nocturnal phase of the circadian cycle,
during which they experience their most active, inquisitive
and responsive period (Gorka and Adamik 1993). As the
rats were maintained on a reverse light/dark cycle, this
enabled us to conveniently test the rats during their activity phase.
One group was used for testing in the 5-CSRTT
(ChAT::Cre+, n = 13; ChAT::Cre−, n = 8), whilst the
second group was subjected to anxiety-profiling tasks,
consisting of the open field (OF) arena, elevated plus maze
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(EPM), and light/dark box (LDB) (ChAT::Cre+, n = 8;
ChAT::Cre−, n = 10). Finally, some of the rats (that had
been subjected to either the 5-CSRTT or anxiety testing)
were subjected to fear conditioning testing followed by
blood/tissue analysis (ChAT::Cre+, n = 5; ChAT::Cre−,
n = 8). During 5-CSRTT training, the animals had their
weight monitored weekly and maintained at 85–95% of
their free feeding body weight. During this period, the
animals received 18 g of laboratory pellet chow once a day
with ad libitum access to water. Animals used for anxiety
profile tasks and fear conditioning followed by blood/tissue analysis had ad libitum access to food and water. OF,
EPM, LDB, fear conditioning testing and blood sampling
occurred between 14:00 and 17:00. The order of behavioral assessment was anxiety profile tasks (OF, EPM and
LDB) followed by the contextual fear conditioning task
(CFCT) and then blood sampling. No sample calculation
was performed to estimate the number of rats used in each
experimental group.
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disruption occurred in the test environment, as a likely influencer of the rat’s behavior.
Elevated plus maze testing

Blind scoring of the rats’ behavioral test performance was
performed using automated computer software. Additionally, the experimenter was blind to genotype during ratderived sample processing. For each behavioral test, rats
were tested in a counterbalanced order with regard to genotype. Following testing of each animal, the apparatus was
thoroughly cleaned with 70% ethanol (EtOH) to eliminate
the residual odors and traces of the previously tested animal.

At least 7 days after conducting OF testing on the rats, the
rats’ exploratory behavior in the EPM was recorded using
the same recording equipment described above. The EPM
was constructed from black and clear Perspex and consisted
of two open arms (110 cm long × 11 cm wide) and two
closed arms (110 cm long × 10 cm wide × 40 cm high),
extending from a central platform, which was raised 50 cm
from the ground. The testing room was illuminated evenly
with white light (intensity 70 lx). The protocol was run as
previously described (Walf and Frye 2007). Briefly, rats
were placed facing the same open arm in the central platform
and exploratory behavior was recorded for 5 min. Animals
were excluded from analysis under the following conditions:
when a rat fell over the edge of the open arms of the maze
and if a noise or other disruption caused the rat to freeze
during testing. The parameters analyzed were time spent in
open arms (% of time), number of entries into open arms (n),
distance traveled (m), number (n) and time spent grooming
(s), number (n) and time spent rearing (s), and average speed
(cm/s). ANY-maze software was used to analyze the videos.
The EPM testing protocol stated that entry into an arm
was only scored when all four paws of the animal had
entered an arm, while a rat that fell over the edge of the
open arms of the maze or froze during testing due to a noise
or other disruption would be excluded.

Open field testing

Light/dark box testing

All behavioral procedures were conducted in a dark (visibility was 5 m), soundproofed room. For measuring behavior
in the OF arena, rats were placed in the center of a circular
field of 900 cm (diameter) × 38.5 cm (height). The apparatus
consisted of an inner field (625 cm in diameter) surrounded
by an outer field (375 cm from inner field edge to field’s
edge). Room temperature (RT) and lighting were identical
to that used for testing in the EPM (see below). Each rat
was recorded for 5 min using a Yi Action Camera (Yi Technology, Seattle, USA) connected to a personal computer,
with subsequent videos analyzed using ANY-maze software
(Stoelting ANY-maze, Wood Dale, USA). Parameters were
time spent in inner field (% of time), number of entries into
inner field, distance traveled (m), number of bouts and time
spent grooming (s), number of bouts and time spent rearing
(s), and average speed (cm/s).
An animal was recorded to have entered either the inneror outer field of the test area when all four paws had been
placed inside either zone. The protocol stipulated that
a rat would be excluded from analysis if a noise or other

Rodents prefer dark and enclosed places, as a strategy
for reducing the risk of predation (Crawley and Goodwin
1980). With this regard, the LDB assay has been deemed
an ethologically relevant measure of anxiety-like behavior
in rodents as it assesses approach versus avoidance behavior, baseline vigilance and defensive behaviors (Lezak et al.
2017). Both groups of rats were subjected to an LDB test
paradigm at least 7 days after completing testing in the EPM.
We utilized an LDB apparatus similar to that described
by Bourin and Hascoe (2003), consisting of a plastic box
divided into two equally sized partitions: a light—(brightly
lit with white walls) and dark (minimally lit with black
walls) chamber. The chambers were divided by means of
a Perspex partition containing an opening that was large
enough for an adult male rat to transverse between the two
chambers, with the opening that was covered by a sliding
door. All ChAT::Cre+ and ChAT::Cre− rats were tested in
the same testing box. Testing was performed in accordance
with previously described procedures (Arrant et al. 2013).
The test commenced with a rat placed in the dark half of

Behavioral procedures
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the box, with the sliding door that was raised simultaneously. Each animal’s behavior was recorded for 5 min using
the recording equipment described above. Through the use
of ANY-maze software, we analyzed the recordings for the
parameters: (1) the latency to enter the light chamber, (2)
total time spent in the light chamber and (3) the number of
entries into the light chamber.
An entry into either the light or dark chamber was scored
when all four paws of the animal had been placed into the
respective chamber to be considered an entry. The only
exclusion criteria that had been preset were conditions of
unforeseen loud noise or other disturbances, for which the
protocol stated that a subject would then be removed from
the analysis.
Five‑choice serial reaction time task
The 5-CSRTT is a well-validated task for assessment of several cognitive functions and manifesting behaviors including
vigilance, impulsivity and compulsivity (Bari et al. 2008).
Training and testing took place in Bussey-Saksida Touch
System chambers (Lafayette Instrument, Indiana, USA) networked to a computer using ‘Whisker’ software. Chambers
were trapezoidal [30 cm (height) × 35 cm (length) × 30 cm
front end (width) × 25 cm rear end (width)], with a touchsensitive liquid crystal display flat screen placed at the front
end. A food magazine was placed at the rear end, into which
45 mg reward sugar pellets (Sandown Scientific, Middlesex,
UK) were dispensed from an external dispenser. Black perspex masks with five evenly spaced square apertures located
basally in the rat’s immediate field of vision were secured in
front of the touch screens. Infrared sensors were located at
the front and rear of the chamber.
Briefly, animals were trained to nose-poke into one of
five briefly illuminated apertures, spaced randomly. The
baseline and training task ended after 30 min or when animals had completed 100 trials. A stimulus duration (SD) of
0.5 s is standard for 5-CSRTT when assessing rats. However,
behavioral output was largely below criteria (≥ 70% accuracy and ≤ 20% omissions) at an average SD of 0.5 s, so an
SD of 0.6 s was instead utilized as the baseline level. Four
ChAT::Cre+ and two ChAT::Cre− animals were excluded
from further testing due to failure to reach final criteria.
After establishing that baseline criteria were consistently
met, rats were assessed using a varied SD probe (0.15, 0.3
and 0.6 s). Variables recorded at each session included: (1)
correct responses; (2) incorrect responses; (3) accuracy
(number of correct responses divided by the total of correct and incorrect responses, expressed as a percentage); (4)
omitted responses; (5) premature responses [responses made
during intertrial interval (ITI)]; (6) perseverative responses
(repeat responses made after a correct response); (7) correct
response latency (time from stimulus presentation until a
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correct response was made); (8) incorrect response latency
(time from stimulus presentation until an incorrect response
was made); and (9) magazine latency (time to collect reward
post-correct response).
Although environmental noise was kept to a minimum,
the 5-CSRTT protocol stated that in case of an unexpected
noise or other disturbance occurring during 5-CSRTT testing, a rat affected would be removed from analysis.

Animal killing and tissue handling for molecular
analyses
At the end of the behavioral assessments, the rats were
killed humanely by exposure to CO2 and the heads were
decapitated. The brains were rapidly removed from the
skull, immediately followed by bilateral microdissection
of the prefrontal cortex (PFC) brain tissue on a prechilled
metal plate. All dissection instruments were prechilled in
powdered dry ice. The specimens were then flash frozen in
liquid nitrogen and stored at − 80 °C until further use within
labeled tubes that were immediately sealed. All steps in the
procedure were performed rapidly to avoid RNA and protein
degradation.
Contextual fear conditioning task
The CFCT is a well-validated behavioral assessment measure that is used for exploring the neural substrates involved
in emotional learning and memory (Tavote et al. 2015; Kim
and Jung 2006). Here, we utilized this Pavlovian conditioning task to monitor HPA-axis functioning in ChAT::Cre+
compared to ChAT::Cre− rats, by measuring levels of blood
plasma markers to an acute stressor. Acquisition and retention testing took place in operant conditioning chambers
(Med Associates, Vermont, US) measuring 30.5 cm (length)
× 32.5 cm (height) × 24.1 cm (wide), with a plexiglass
door and ceiling and metal paneling on the back and on the
sides. The floor of the chamber consisted of a metal grid
through which a mild electrical shock (115 VAC, 60 Hz;
ENV-224AMWN, Med Associates) was delivered. Testing
chambers were placed in sound and light attenuating boxes
that had been networked to a computer using ‘Whisker’
software (Campden Instruments Ltd., Loughborough, UK)
(Cardinal and Aitken 2010). On the day of training, each
rat was placed in the chamber for 3 min, during which time
it received no stimulation or cues. At the end of the third
minute, rats received 3× 1 s foot shocks of 1 mA intensity
with 60 s intershock intervals. Animals were removed 30 s
after the final foot shock, which placed acquisition duration at 330 s. Retention testing took place 24 h later, with
each animal being placed in their respective chamber and
their behavior recorded for 8 min. Freezing behavior (lack
of movement, except for breathing) was analyzed using
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Matlab software (MathWorks, Massachusetts, US). Blood
plasma samples were collected from each rat to represent
the baseline, acquisition and retention phases of the CFCT,
with procedural details provided below.

Blood plasma analysis of corticosterone, leptin
and glucose levels
Blood was taken sublingually under general anesthesia (5%
isoflurane). Baseline samples were collected 2 days prior
to initiating the task protocol, at the same time of day that
blood would be collected on contextual fear conditioning
testing days, which occurred 25 min post-acquisition training and also the same length of time post-retention testing.
Approximately, 1 ml samples were taken using ethylenediaminetetraacetic acid (EDTA)-primed vials (Thermo
Fisher Scientific, UK), which were then placed on ice and
centrifuged at 3000×g at 4 °C for 20 min. Plasma was aliquoted into Eppendorf tubes for corticosterone level analysis. Corticosterone (Cat No. ADI-901-097, Enzo Life Sciences, Devon, UK; RRID: AB_2307314) and leptin (Cat No.
ADI-900-015A, Enzo Life Sciences, UK) quantification was
done using enzyme-linked immunoassay (ELISA) kits with
glucose quantification that was done using a colorimetric
assay kit (Cat No. 10009582, Cayman Chemical, Michigan,
USA), all according to the manufacturer’s instructions. The
plasma corticosterone and leptin concentration levels are
given as ng/ml, while glucose plasma concentration is given
as mg/ml.

Quantitative RT‑PCR
To examine the copy number of mouse VAChT transgene, we
used primers specific for the mouse VAChT gene (VAChTintron forward: GAGAGTACTTTGCCTGGGAGGA and
VAChT-intron reverse: GGC  CAC AGTA AG ACC  T CC
CTTG) and actin primers (actin forward: TATCCTGGC
CTCACTGTCCA and actin reverse: AAGGGTGTAAAA
CGCAGCTCA), for normalization. Actin primers were able
to efficiently amplify both mouse and rat genes. Both primer
pairs showed efficiency above 95% and similar amplified
fragment size. We compared amplification of Cre+ rat DNA
to Cre− rat DNA and also mouse DNA. Briefly, DNA was
isolated from either rat (ChAT::Cre+, n = 5; ChAT::Cre−, n
= 8) or mouse (n = 4) PFC brain tissue samples that had been
pooled according to the genotype, using the phenol–chloroform extraction protocol (Guzman et al. 2011), precipitated
with isopropanol and washed twice on 70% EtOH. The DNA
pellet was dissolved in ultra-pure water and concentration
was determined based on Nanodrop measurements. PCR
reaction was prepared using the Sensifast SYBR Green kit
(Cat No. BIO-98020, Bioline, UK). We used a 10-μl total
volume, with each primer at concentration of 200 nM and
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a genomic DNA concentration of 10 ng. Technical triplicates were applied and melting curve was checked for each
run. Quantitative PCR (qPCR) was performed, using the
C1000TM Thermal Cycler, CFX96 Real-Time System
(Bio-Rad) at the following settings: step 1: 95 °C for 5 min;
step 2: 95 °C for 30 s; step 3: 60 °C for 10 s; step 4: 72 °C
for 10 s; step 5: plate reading. Steps 2–5 were repeated 40
times. Copy number of mouse VAChT transgene in rats was
determined by the 2−ΔΔCq method (Livak and Schmittgen
2001). The mean Cq of the mouse VAChT gene and the mean
Cq of actin gene in the ChAT::Cre+ and ChAT::Cre− rats
were calculated with fold-change that was determined using
the 2−ΔΔCq method. One group was used for testing in the
5-CSRTT (ChAT::Cre+, n = 13; ChAT::Cre−, n = 8), whilst
the second group was subjected to anxiety-profiling tasks,
consisting of the OF arena, EPM and light/dark box (LDB)
(ChAT::Cre+, n = 8; ChAT::Cre−, n = 10).
For quantifying VAChT mRNA expression, total RNA
was isolated using the Aurum Total RNA Fatty and Fibrous
Tissue Kit (Cat no. 7326830, Bio-Rad, Hercules, CA, USA),
in accordance with the manufacturer’s instructions, using
the remainder of the genotype-pooled rat PFC samples
(ChAT::Cre+, n = 5; ChAT::Cre−, n = 7). cDNA was synthesized using a High Capacity cDNA reverse transcription
kit (Thermo Fisher Scientific, UK), again following the manufacturer’s manual. cDNA was then diluted and the quantitative Real-Time PCR (RT-PCR) reaction was performed on a
C1000™ Thermal Cycler, CFX96 Real-Time System (BioRad) using Bioline Sensifast SYBR Green (BIO-98020)
using the following PCR cycling conditions: step 1: 95 °C
for 5 min; step 2: 95 °C for 10 s; step 3: 60 °C for 10 s;
step 4: 72 °C for 10 s; step 5: plate reading, with steps 2–5
repeated 40 times. The primer pairs were as follows: mouse
VAChT-exon forward: CCCT
 TTT
 GAT
 GGC
 TGT
 GA, mouse
VAChT-exon reverse: GGGC
 TAG
 GGT
 ACT
 CAT
 TAG
 A. Rat
β-actin was used as reference gene for data normalization,
as the actin primer can detect both rat and mice mRNA and
genomic DNA. For detecting actin, the following primer
pairs were used: rat β-actin forward: TATCCTGGCCTC
ACTGTCCA, rat actin reverse: AAGGGTGTAAAACGC
AGCTCA. Technical triplicates were applied and melting
curve was checked, as a standard procedure for each plate.

Western immunoblotting
The PFC rat brain tissue samples, pooled according to
genotype, were lysed using radioimmunoprecipitation
assay (RIPA) lysis buffer, followed by separation of proteins on 10% SDS-PAGE (sodium dodecyl sulfate-polyacrylamide) gels. Proteins were transferred to ImmobilonP polyvinylidene difluoride (PVDF) membranes (Cat No.
IPVH00010, Millipore, UK) using a semi-dry transfer apparatus (Trans-Blot Turbo™, Bio-Rad) run at 20 V for 1 h. The
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membrane was then blocked in 5% (w/v) powdered skimmed
milk in Tris-buffered saline/0.1% Tween 20 (TBS-T) for 1 h,
followed by incubation overnight at 4 °C with a primary
antibody raised against α-VAChT (1:1000, rabbit polyclonal,
Cat No. 139-103, Synaptic Systems, Göttingen, Germany;
RRID: AB_10893979) diluted in blocking solution. The next
morning, after washing 3× in TBS-T, the membrane was
incubated with the secondary antibody for 1 h at RT. The
membrane was then washed again in TBS-T before visualizing the signal using the ECL-plus kit (Cat No. RPN2236,
GE Healthcare, UK) in the Bio-Rad Chemi-DocTm Imaging system. Following such washes, the membrane was
stripped and then probed for α-synaptophysin using a rabbit
polyclonal antibody (1:2000, Cat No. 32594, Abcam, UK;
RRID: AB_778204), dissolved in 5% bovine serum albumin
(BSA)/TBS-T, as an internal loading control. Protein densities on Western blots were analyzed and quantified with v.
1.45 s ImageJ software (http://imagej.nih.gov/ij/; provided
in the public domain by the National Institutes of Health,
Bethesda, MD, USA).

Statistical analysis
All data are expressed as mean ± standard error of the mean
(SEM). SPSS Statistics (v.22, IBM) software was used for
statistical analysis of the data. The distribution of the data
was examined using the D’Agostino–Pearson omnibus test.
Mouse VAChT gene copies and VAChT protein comparisons
between genotypes were analyzed using an independent Student’s t test. A one-way ANOVA followed by the Tukey’s
multiple comparison test was used to analyze VAChT mRNA
levels between ChAT::Cre+ rats, ChAT::Cre− (Wt) rats, and
also Wt mice, which served as an additional control for the
VAChT mRNA measures. Corticosterone, leptin and glucose data were analyzed a using mixed-effects ANOVA with
time-point being the within-subjects factor and genotype the
between-subjects factor. Freezing scores for fear conditioning and all anxiety profile task parameters were compared
using an independent samples t test. Baseline 5-CSRTT data
were analyzed in a mixed-effects ANOVA with session as
within-subjects factor and genotype as between-subjects factor. The varied SD probe was analyzed similarly with session and SD time as within subject and genotype as between
subject factors. Any main effects were examined using the
Tukey’s HSD (honestly significant difference) post hoc comparison, with interactions that were explored using a Fisher’s
LSD (least significant difference) post hoc analysis; from
both tools, the effect size (η2) was calculated. Any extreme
outliers were identified using the ‘outlier labeling rule’ and
removed from data analysis (Hoaglin et al. 1986). The rule
entails that the difference between the lower and upper quartile is multiplied by a factor ‘g’. Due to the published advice
advising that the initially suggested ‘g’ value of 1.5 (Hoaglin
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et al. 1986) proved inaccurate in some instances and that a
multiplier value of 2.2 generates valid results more often
(Hoaglin and Iglewicz 1987), we utilized a ‘g’ value of 2.2
to the datasets generated for the current project. p values
were designated as: ***p < 0.001, extremely significant;
**p ≤ 0.01, highly significant; *p ≤ 0.05, significant and p
> 0.05, non-significant (NS).

Results
ChAT::Cre+ rats exhibit an anxiolytic‑like
and hypermobile behavioral profile
Anxiety profiles were evaluated from assessing the rats’
behavior in the OF, EPM and the LDB. The behavioral
time-line for anxiety profiling is shown in Fig. 1a. In the
OF, ChAT::Cre+ rats displayed a hypermobility profile compared to ChAT::Cre− siblings, with a significantly increased
average traveling speed (***p = 0.0008) (Fig. 1b), a greater
distance covered (**p = 0.0063) (Fig. 1c), as well as rearing more often (***p = 0.0006) (Fig. 1d) and, relatedly,
spending more time rearing (***p = 0.0006) (Fig. 1e). The
ChAT::Cre+ also appeared anxiolytic by entering the inner
diameter significantly more than ChAT::Cre− siblings (***p
= 0.0002) (Fig. 1f), while also spending significantly more
time within the inner field of the test arena, compared to the
ChAT::Cre− rats (***p = 0.0002) (Fig. 1g).
Similarly, ChAT::Cre+ rats showed higher average speed
of movement (*p = 0.014) (Fig. 2a) and covered more distance in the EPM than their ChAT::Cre− siblings (***p =
0.0005) (Fig. 2b) over the entire 5 min that rats were tested
in the EPM; these findings again suggested a general hyperlocomotion profile. In this test, a similar trend was also seen
to that in the OF test, for ChAT::Cre+ rats to rear more (**p
= 0.0017) (Fig. 2c) and for longer (*p = 0.0134) (Fig. 2d)
for the full testing period within the EPM, than was seen
for ChAT::Cre− rats. ChAT::Cre+ rats’ general anxiolytic
tendency was reinforced by displaying an increased tendency to visit the open arms of the EPM more often than
ChAT::Cre− rats (***p = 0.0006) (Fig. 2e) and spending
significantly more time in the open arms of the maze (*p =
0.0403) (Fig. 2f) compared to ChAT::Cre− rats.
In the LDB, ChAT::Cre+ rats entered the light chamber significantly more frequently (*p = 0.0132) (Fig. 3a),
exhibited greater average duration of time in the light
chamber (*p = 0.0118) (Fig. 3b) and subsequently, also
spent less time in the dark chamber of the test apparatus
(*p = 0.0277) (Fig. 3c). Taken together, use of multiple
experimental paradigms revealed that the ChAT::Cre+ rat
model displays spontaneous locomotion and adaptation
to a novel, anxiety-evoking environment that differs from
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Fig. 1  The rats’ behavior was
assessed for 10 min in the OF
arena to measure locomotion
and anxiety-like behavior. a The
timeline of the anxiety-related
and locomotion test procedures performed on the rats are
shown; all rats performed the
same behavioral tests in the
order shown. To investigate
the acute effect of foot shock at
post-acquisition and post-retention stage on plasma corticosterone, leptin and glucose levels,
blood samples were collected
at the time-points shown, to
compare to baseline levels. In
the OF test, the behavioral profile of ChAT::Cre+ rats (n = 8)
differed from their ChAT::Cre−
siblings (n = 10). Taken
together, the parameters b average speed of movement, c total
distance traveled, d number of
rearings made and also e the
time spent rearing during the
test, indicated that ChAT::Cre+
rats were hypermobile. Other
parameters like f number of
entries into inner field and (g)
time spent in the inner field, further revealed that ChAT::Cre+
rats were in a mixed hypermobile and anxiolytic state. All
data are presented as the mean
± SEM. *p ≤ 0.05, **p ≤ 0.01
and ***p < 0.001, compared to
ChAT::Cre− rats

the baseline behavioral profile seen for non-transgenic littermate rats of a similar strain.
None of the rats’ performance scores were excluded
from the final analysis for the anxiety-profiling tasks,
based on the exclusion criteria set for each behavioral
measure (for a description of these, please see the “Materials and methods”). In addition, no animal died during behavioral testing. Hence, data collected for all rats
tested in the OF, EPM and LDB were included in the final
analyses.
ChAT::Cre+ rats make more errors of omission and
fewer perseverative responses than Chat::Cre− rats in the
5-CSRTT.
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Figure 4 summarizes the results of the behavior displayed by the two genotypes in the 5-CSRTT. No differences were detected between the two groups in terms of
choice accuracy (p = 0.714, NS) (Fig. 4a), the number of
correct responses (p = 0.105, NS) (Fig. 4b) or the number
of incorrect responses (p = 0.814, NS) (Fig. 4c). Relatedly,
the measures ‘mean delay to make a correct response’ (p
= 0.364, NS) (Fig. 4d) or to make an incorrect response (p
= 0.061, NS) (Fig. 4e) were also left unchanged between
transgenic and non-transgenic rats. Furthermore, the measures ‘number of premature responses’ (p = 0.946, NS)
(Fig. 4f) and ‘mean latency of reward collection following a correct response’ (p = 0.308, NS) (Fig. 4g) were also
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Fig. 2  Anxiety-like behavior
in the rats was further assessed
in the EPM maze, where the
task is based on an approachavoidance conflict and greater
avoidance of the open arms is
interpreted as an exhibition of
higher anxiety levels. The findings reflected those obtained for
OF testing, with regards to both
general ambulation and anxietylike behavior. Over the duration
of the test (5 min), ChAT::Cre+
rats (n = 8) traveled on average at a greater speed and b
covered a greater distance than
the ChAT::Cre− rats (n = 10).
Compared to ChAT::Cre− rats,
ChAT::Cre+ ones also revealed
hypermobility by making c
significantly more rearing bouts
and d spending more time rearing. ChAT::Cre+ rats also made
e more entries into the open
arms of the EPM apparatus and
f spent more time in the open
arms than their ChAT::Cre−
siblings, reflecting the general
anxiolytic profile detected
for the ChAT::Cre+ rats seen
during testing in the OF. All
data are presented as the mean
± SEM. *p ≤ 0.05, **p ≤ 0.01
and ***p < 0.001, compared to
ChAT::Cre− rats

similar between ChAT::Cre+ and ChAT::Cre− rats. However, compared to their ChAT::Cre− siblings, ChAT::Cre+
rats made significantly more errors of omission (*p = 0.016,
η2 = 0.373) (Fig. 4h), but fewer perseverative responses (**p
= 0.006, η2 = 0.456) (Fig. 4i).
During a version of the 5-CSRTT, where the SD probe
length was varied, a main effect of SD on accuracy was
detected (**p = 0.002) (Fig. 5a) that featured as decreasing accuracy as SD times became shorter. This effect was
caused by the overall tendency of ChAT::Cre+ rats to
make fewer correct responses (*p = 0.05) (Fig. 5b), implying more incorrect responses (**p = 0.009) (Fig. 5c) as the
SD decreased, compared to ChAT::Cre− siblings. However, no significant interaction was detected between SD

variation and genotype. Between-subject genotype analysis showed that upon variable and, therefore, increased
demand conditions, ChAT::Cre+ rats made fewer perseverative responses compared to ChAT::Cre− ones
(*p = 0.018, η 2 = 0.410) (Fig. 5d). This was similar to
baseline behavior, to indicate that this phenotypical difference could be regarded as robust. When comparing
perseverative responses assessed for different SD times,
this decrease was significant at the longest duration probe
tested for, namely 0.15 s (**p = 0.005) (Fig. 5d). The tendency for ChAT::Cre+ rats to omit more responses compared to their baseline behavior was not seen in the varied
SD probe (p = 0.287, NS) (Fig. 5e). Differences were also
not seen between genotypes in the varied SD probe when
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Fig. 3  The LDB is another
conventional anxiety test that is
based on the innate aversion of
rodents to brightly illuminated
areas, which was utilized to test
unconditional anxiety responses
in the rats. The ChAT::Cre+
rats (n = 8) showed a greater
preference for the light compartment of the box compared to
their ChAT::Cre− siblings (n
= 10). Behavioral parameters
assessed were: a total number
of entries made into the light
chamber, b time spent in the
light chamber and c latency
time for rats to enter the light
chamber. All data are presented
as the mean ± SEM. *p ≤ 0.05,
compared to ChAT::Cre− rats

number of premature responses were assessed (p = 0.389,
NS) (Fig. 5f).

ChAT::Cre+ rats display a biologically intact stress
response to an acute stressor in a CFCT paradigm
Previous studies showed that the cholinergic system could
play a role in HPA activation and corticosterone levels
(Newman et al. 2001; Paul et al. 2015). To investigate the
effects of altered cholinergic modulation on physiological
stress responses, we measured plasma levels of corticosterone at baseline and post-retention testing in the CFCT.
With this regard, several studies have demonstrated a positive relationship between circulating corticosterone levels
and contextual conditioning (Pugh et al. 1997; Thompson
et al. 2004).
The level of freezing, measured during retention testing,
did not show any significant difference between genotypes
(p = 0.642, NS) and produced an average of ~ 90% for each
group (Fig. 6a). When all rats were considered together,
without accounting for genotype, a significant increase of
corticosterone from baseline to fear acquisition was seen
(*p < 0.05), and also when baseline levels were compared
to levels reached at the retention phase of the CFCT (***p
< 0.001) (Fig. 6b). However, this effect was independent of
genotype (p = 0.618, NS), with no interaction seen between
genotype × sample point either (p = 0.199, NS). Post hoc
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analysis revealed high statistical significance between differential levels of circulating corticosterone levels from
baseline to retention phase for ChAT::Cre− litter mates
(***p < 0.001); however, a similar comparison made for
ChAT::Cre+ rats proved non-significant (p = 0.057, NS)
(Fig. 6b).
Analysis of plasma glucose levels revealed no significant
difference between sample points (p = 0.196, NS), when
comparing the genotypes (p = 0.095, NS) or at a sample
point × genotype interaction level (p = 0.290, NS) (Fig. 6c).
Analysis of leptin levels revealed no significant difference in
main effect of sample point (p = 0.50, NS) or of genotype
(p = 0.933, NS), while no significant interaction effect was
observed either (p = 0.108, NS) (Fig. 6d).

Higher levels of VAChT mRNA and protein
expression in ChAT::Cre+ rats compared to Wt rats
qPCR results revealed that all Long-Evans ChAT::Cre+ rats
analyzed here contained two copies of the mouse VAChT
gene relative to ChAT::Cre− rats (***p < 0.001) (Fig. 7a).
Mouse VAChT mRNA was variable within individual rats,
with some having levels similar to mouse controls (Fig. 7b).
However, overall, the expression of mouse VAChT mRNA in
ChAT::Cre+ rats achieved approximately 50% the levels of
mouse controls (Fig. 7b), which indicates the expression of
the mouse VAChT gene inserts in the rat genome. Supporting
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Fig. 4  Performance in the
5-CSRTT assessed for differences in attention, impulsivity and cognitive flexibility
between the transgenic and
Wt rats. ChAT::Cre+ rats (n
= 13) made significantly more
omission errors and fewer
perseverative responses than
their ChAT::Cre− siblings (n
= 8) during 5-CSRTT testing,
which measured the following
parameters: a choice accuracy;
b average number of correct
responses; c average number of
incorrect responses; d latency
to make a correct nose poke
response following stimulus
presentation; e latency to make
an incorrect response following
stimulus presentation; f average
number of premature responses;
g latency to collect sugar pellet
reward from food magazine
after a correct response; h average number of errors of omission and i average total number
of perseverative responses. All
data are presented as the mean
± SEM. *p ≤ 0.05, **p ≤ 0.01,
compared to ChAT::Cre− rats
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Fig. 5  A version of the
5-CSRTT, where SD length
was varied (0.6, 0.3 and 0.15 s),
further measured attentiveness,
impulsivity, processing speed
and distractibility in the rats.
SD length variance exerted an
overall significant effect on a
choice accuracy. This was since,
compared to ChAT::Cre− rats
(n = 8), the ChAT::Cre+ ones
(n = 13) made on average, b
less correct responses and,
therefore, c more incorrect
responses, as SD decreased.
d ChAT::Cre+ rats made
less perseverative responses
compared to ChAT::Cre− ones,
with the number of perseverative responses that decreased
most significantly at the longest
duration probe, namely 0.15 s.
e As detected in the standard 5-CSRTT, a tendency by
ChAT::Cre+ rats to omit more
responses compared to baseline
behavior was not repeated. f
Groups revealed similar levels
of premature responses. All data
are presented as the mean ±
SEM. **p ≤ 0.01, compared to
ChAT::Cre− rats

the gene copy and the mRNA analysis, VAChT protein levels were increased close to 50% in ChAT::Cre+ rats when
compared to Cre− siblings (**p = 0.004) (Fig. 7c). This
result supports the notion that the increased VAChT expression found in ChAT::Cre+ rats may also increase ACh levels
within synaptic vesicles, as had previously been reported for
BAC transgenic mice that express channelrhodopsin protein,
a light-gated ion channel, under control of the ChaT promoter (Sugita et al. 2016).

Discussion
The current findings show that, compared to their Wt siblings, Long-Evans ChAT::Cre+ rats exhibit altered baseline
behavior, affecting gross locomotor function, anxiety-related
behavior as well as some aspects of sustained attention. We
also molecularly analyzed the PFCs collected from the
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rats, with this brain region that receives dense cholinergic
innervation and also connects directly and indirectly via
cholinergic projection neurons with multiple brain areas, to
provide important modulation of cortical function (Bloem
et al. 2014; Tingley et al. 2015). The analysis revealed that
these behavioral changes were paralleled by altered expression of VAChT within the PFC, at both a gene and protein
level, with VAChT being a key molecular mechanism in
the transport machinery of ACh from the cytoplasm to the
lumen of synaptic vesicles, to ultimately release ACh into
the synaptic cleft. Physiologically, an increase in levels of
this functional transporter could alter ACh levels at the synapse (Kolisnyk et al. 2013; Sugita et al. 2016; Nagy and
Aubert 2012), which could alter cholinergic tone and, subsequently, behavioral phenotype in rodents. Hence, the current findings demonstrate that expression of the ChAT-BAC
construct makes these rats different from their Wt siblings,
similar to findings previously reported using BAC transgenic
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Fig. 6  Freezing behavior and blood plasma analysis of HPA-axis biomarkers performed on ChAT::Cre+ (n = 5) and ChAT::Cre− (n = 8)
rats at baseline (2 days before initiating the task protocol), with testing that was then repeated at the fear acquisition and fear retention
stages of a CFCT. a Freezing scores acquired for retention testing;
b comparison of corticosterone blood plasma levels between genotypes at the different CFCT testing phases; c a similar comparison
made for glucose blood plasma levels and for d leptin blood plasma

levels. The significant increase in blood plasma corticosterone levels seen in both rat genotypes from baseline to a repeat analysis soon
after rats completed the fear acquisition and also the fear retention
test phases, indicates that all rats of this strain, regardless of the genotype (ChAT::Cre+ vs. Wt), respond in a biologically intact manner to
aversive conditioning. All data are presented as the mean ± SEM. *p
≤ 0.05 and ***p < 0.001, compared to both genotype rats’ baseline
measurements

mice engineered to express a light-sensitive protein under
control of the ChAT promoter (Kolisnyk et al. 2013; Chen
et al. 2018).
As was reviewed by Prado et al. (2013), ACh synthesis
depends on the uptake of the ACh precursor, choline by
CHT1 [high-affinity choline transporter/SLC5A7 (solute
carrier family 5 member 7)] that mainly expresses within
cholinergic neurons, yet presents in certain non-neuronal
cells also. In the cytoplasm of synapses, ACh is then
synthesized by the enzyme ChAT, with ACh that is then
loaded into synaptic vesicles by VAChT. Upon arrival of
a nerve impulse, the vesicles fuse to the plasma membrane and release ACh that signal through nicotinic and
muscarinic cholinergic receptors. ACh is rapidly degraded
into acetate and choline by the enzyme AChE (acetylcholinesterase). In the current work, we have only evaluated
expression levels of VAChT, in line with other studies utilizing BAC transgenic mice for expressing a light-sensitive

protein under control of the ChAT promoter that also
restricted molecular analysis to VAChT, as a valid indicator of cholinergic tone (Kolisnyk et al. 2013; Chen et al.
2018). The importance of functional vesicular storage
and synaptic “loading” of ACh, which is modulated by
VAChT, acts as a required step for ACh release. In addition, decreased VAChT expression has been shown to lead
to several motor and cognitive dysfunctions (Prado et al.
2006; Martyn et al. 2012), some of which was presently
behaviorally evaluated for in the ChAT::Cre+.
To ensure a comprehensive understanding of the levels
at which altered cholinergic metabolism and transmission
might be altered as a result of the ChAT::Cre+ genotype,
future work should undertake gene and protein expression analysis of other important mediators in this process,
including but not limited to ChAT, CHT-1, AChE, but also
muscarinic and nicotinic receptors for signaling ACh. Such
eventual comprehensive profiling will inform greatly on the
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Fig. 7  Measurement of prefrontal cortical VAChT mRNA
and protein levels. a qPCR
results indicated additional
mouse VAChT gene copies in
all ChAT::Cre+ rats (n = 5)
compared to ChAT::Cre− controls (n = 8). This translated
to b increased mouse VAChT
mRNA expression in Cre+ (n
= 5) and Cre− (n = 7) siblings
compared to Wt mice (n = 4)
and also c increased VAChT
protein expression in PFC brain
samples of Cre+ (n = 5) and
Cre− (n = 8) rats. All data
are presented as the mean ±
SEM. *p ≤ 0.05, **p ≤ 0.01
and ***p < 0.001, compared to
ChAT::Cre− rats and Wt mouse

design of experimental work involving this popular experimental rat tool.
Our data indicated a hypermobile state for ChAT::Cre+
rats over Wt ones in several parameters assessed in the OF,
EPM and LDB. The observed locomotor arousal in the transgenic rats is consistent with the previously proposed mechanism that instantaneous ACh synaptic release correlates
positively with increased activity by rodents seen in novel
environments (Mizuno et al. 1991; Cohen et al. 2012), while
ACh is known to fulfill a complex role in locomotor control,
which includes modulating the dopaminergic system (Rice
and Cragg 2004). Confirmation of the specific mechanisms
for the observed hyperactive spontaneous activity awaits
brain region-specific VAChT overexpressing rat models.
This result differs from those presented by Azzopardi
et al. (2018) who observed no hyperlocomotive phenotype
in ChAT::Cre+ rats, although enhanced motor endurance
had previously been reported for the ChAT-ChR2-eYFP

13

(enhanced Yellow Fluorescent Protein) BAC transgenic
mouse line (Kolisnyk et al. 2013). It is worth noting though
that the study by Azzopardi et al. (2018) made use of a
single metric (distance traveled) for assessing abnormal
mobility, with the group using a 45 × 45 cm square OF box.
Instead, we made use of a circular test apparatus, with the
shape of OF arena (circular, square or rectangular) that has
been identified as an important variable that can influence
OF performance by rodents (Sestakova et al. 2013). Similarly, this research group only assessed the time spent in the
outer perimeter in the same apparatus as indicator of anxiety.
Lastly, Azzopardi et al. (2018) utilized rats in the experimental procedures at a slightly older age, at 10–14 weeks,
whereas rats used in the current study ranged between 8
and 10 weeks of age. However, Long–Evans rats are considered to have reached adulthood by 8 weeks of age (Snyder et al. 2009; Jackson et al. 2016), while the age ranges
of rats used in the present work do overlap somewhat with
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that of the study by Azzopardi et al. (2018), allowing for
reasonable confidence that the differences in experimental
outcomes between these two studies is likely and at least not
exclusively due to age-related differences. However, differences in the age of experimental rats have been highlighted
as a potentially critical experimental variable, to especially
account for changes in neurotransmitter release and receptor
activation, that appear to alter substantially, especially over
early stages of development (McCutcheon and Marinelli
2009). Considering the differences in testing conditions
and the characteristics of the experimental rats used in the
current study compared to those used by Azzopardi et al.
(2018), we conclude that our ambulation and anxiety results
may not be directly comparable.
Our results also reveal ChAT::Cre+ rats to be anxiolytic,
as was assessed in three frequently used tests of anxiety-like
behavior, with such tests that consistently demonstrate the
ability to reveal anxiolytic or anxiogenic profiles of rodents
using either pharmacological- or transgenic manipulations (Crawley 1985; Belzung and Griebel 2001; Prut and
Belzung 2003). This result suggests that modest levels of
VAChT overexpression at both the gene and protein level,
previously shown to increase ACh release and, therefore,
render animals hypercholinergic (Sugita et al. 2016; Janickova et al. 2017), associate with an anxiolytic behavioral
profile in the ChAT::Cre+ rats. The findings reflect those
from another hypercholinergic mouse model that also overexpresses VAChT at the gene and protein level, with such
mice that showed enhanced exploration of novel environments and, therefore, anxiolytic-like behavior, when compared to C57BL/6J (B6) control mice (Nagy and Aubert
2013). In this work, use was made of the B6eGFPChAT
congenic mouse model that contains four genomic copies of
the cholinergic gene locus, which encompasses the promoter
and coding regions of both VAChT and ChAT (Tallini et al.
2006; Nagy and Aubert 2012). As earlier work demonstrated
increased VAChT gene and protein expression in congenic
B6eGFPChAT mice (Nagy and Aubert 2012), this experimental model allows for evaluating whether increasing the
vesicular storage and release of ACh is sufficient for eliciting
changes in behavioral activity.
Relatedly, previous studies showed that exposure to novel
stimuli (i.e., novel environments) associates with cholinergic
activation and increased ACh release (Thiel et al. 1998; Giovannini et al. 2001), while others showed that modulation
of central cholinergic systems regulate emotional processes
including anxiety and stress (Podhorna and Franklin 1999,
2000; Janickova et al. 2019). However, the effects of ACh on
anxiety-like behavior in rodents has proved complex, with
increased ACh release that evoked both anxiolytic and anxiogenic reactions (File et al. 1998, 2000), which may relate to
brain region-specific configurations of ACh receptors (File
et al. 2000; Labarca et al. 2001).
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The cholinergic system has been shown to play an
important role in attentional mechanisms. Selective lesioning of the Ch5 cholinergic cell group of the pedunculopontine nucleus (PPN) (Mesulam et al. 1984), a rostral
brainstem nucleus, resulted in a deficit shown during tests
assessing for sustained attention, which manifested as a
significant decrease in the number of correct responses
and an increase in response latency (Cyr et al. 2015). Similarly, cholinergic-specific lesions made in rats to the Ch4
cholinergic cell group located in the nucleus basalis magnocellularis (NBMc), the rat homologue of the nucleus
basalis of Meynert (NBM), by means of 192 IgG-saporin
infusions, also produced attentional impairments along
with decreased levels of ACh in the PFC (McGaughy et al.
2002). Moreover, attentional impairments are deemed a
core feature of AD and have been shown to be caused,
at least in part, by damage sustained by the NBM, which
undergoes significant neuronal loss during progressive AD
(Ferreira-Vieira et al. 2016).
Kolisnyk et al. (2013) showed that BAC transgenic mice
generated to express the light-gated ion channel, channelrhodopsin-2, under control of the ChAT promoter, with such
animals that are frequently used for dissecting out the relative contribution of cholinergic circuits in behavior, display
severe deficits in several domains of cognitive function, and
that this may be due to VAChT overexpression seen in such
mice. In particular, transgenic mice were impaired in tasks
assessing the domains spatial and working memory. Interestingly, Nagy and Aubert (2015) reported, using hypercholinergic congenic B6eGFPChAT aged mice, improved spatial
memory acquisition during testing in the Morris water maze,
to reveal a consensus between VAChT overexpression and
improved spatial navigation during normal aging. The study
further demonstrated an association between the mice’s augmented memory acquisition and enhanced dendritic ramification of adult-born neurons seen in the hippocampus, and
at progressive ages. Since cholinergic signaling was previously shown to contribute to the dendritic expansion of target neurons (Höhmann et al. 1991), the study by Nagy and
Aubert (2015) supports a role for cholinergic input to the
hippocampus as a mechanism underlying the formation of
dendritic networks to support formation of spatial memories.
Kolisnyk et al. (2013) also reported that the transgenic
mice exhibited significantly more premature responses during the 5-CSRTT, a behavioral paradigm frequently used
for evaluating attention and impulsivity in animal models. This result differed from our current findings, which
did not detect a similar deficit for the transgenic rats when
subjected to either the self-paced version of the 5-CSRTT,
or when the SD was varied during testing. Interestingly,
increased premature responding has been associated with
depletion of another monoamine neurotransmitter, serotonin (Fletcher et al. 2013; Humpston et al. 2013); hence, our
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results seemingly agree that a cholinergic imbalance in the
brain do not manifest as this 5-CSRTT parameter.
However, the construct ‘impulsivity’ encompasses various dimensions, namely motor impulsivity which refers to
acting without thinking, cognitive impulsivity referring to
rapid decision taking and non-planning impulsivity, referring to a present orientation (Patton et al. 1995). Furthermore, 5-CSRTT performance differences have been reported
to exist between mice and rats, including a strategy bias with
rats that showed greater reliance on a temporal strategy than
mice did, resulting in more guessing if their timing was poor,
and manifesting as premature responses (Fletcher et al.
2007). First, for validating whether differences exist between
mice and rats in 5-CSRTT performance, the protocol should
be standardized, including intertrial interval (ITI) lengths.
Species differences in baseline neurotransmitter concentrations could also play a role (Fitzgerald 2009). In addition,
given the complexity of mechanisms underlying 5-CSRTT
parameters, including impulsivity, it is unlikely that a single
brain function abnormality would underlie species differences, calling for considering interacting neurochemistry
systems as the plausible basis of the observed interspecies
differences in 5-CSRTT performance.
Our results also show that ChAT::Cre+ rats make significantly more errors of omission than their Wt siblings,
although this effect did not persist when rats were tested with
a variable attentional load as a result of shorter or longer it
is. Although accuracy was unaffected between the transgenic
and Wt rats, this arguably points at a deficit in sustained
attention, since the ChAT::Cre+ rats showed an increase
in omissions, while latency parameters were left largely
unaffected. Multiple studies have suggested that cholinergic signaling, especially when mediated by α4β2 nicotinic
acetylcholine receptors, underlies altered responses in this
attentional parameter measured in the 5-CSRTT (Shoaib and
Bizarro 2005; Semenova et al. 2007). However, again multiple interacting neuromodulatory systems might form the
neurochemical substrate of this deficit, as several studies
suggested that enhanced midbrain dopaminergic activity in
rats influenced trial omissions, although the direction of the
effect was unpredictable (Granon et al. 2000; Agnoli et al.
2013; Boekhoudt et al. 2017). It has been suggested that
the monoaminergic and cholinergic systems may play separable roles in different aspects of performance controlled
by the 5-CSRTT (Robbins 2002). In the case of response
omissions, motivational factors have been deemed important
for driving this behavioral change, and not merely attentional deficits, with dopamine that plays an established role
in reward-motivation behavior mechanisms (Salamone and
Correa 2012).
We also found that ChAT::Cre+ rats made significantly
fewer perseverative responses in the 5-CSRTT, with this
parameter that is commonly utilized as a reference for

13

Brain Structure and Function (2019) 224:3095–3116

compulsive behavior as well as cognitive inflexibility,
defined as the inability to adapt to goal-directed behavior in
response to changing environmental demands (Gilbert and
Burgess 2008; Eagle and Baunez 2010). Deficits in the ability to flexibly update behavior are observed in various neurological and psychiatric conditions including PD (Cools et al.
2001), obsessive-compulsive disorder (OCD) (Chamberlain
et al. 2008), drug addiction (Everitt et al. 2007), attention
deficit/hyperactive disorder (ADHD) (Rubia et al. 2009) and
pathological gambling (Koehler et al. 2013). The balance
of evidence suggests that the PFC and striatum, which form
part of the portico–basal–thalamic circuit, co-modulate cognitive flexibility, while a multitude of studies demonstrated
that ACh transmission facilitates this process (Prado et al.
2017). With this regard, several studies have shown that
cortical cholinergic manipulations selectively affect aspects
of this cognitive domain with PFC nicotinic receptors that
appear to play an important modulatory role in this process
(Allison and Shoaib 2013). For example, in old rats (Tait
et al. 2013; Nikiforuk et al. 2015), rat models of schizophrenia (Alexander et al. 2013), and in rats that sustained
immunolesioning of the basal forebrain cholinergic neurons
(Cutuli et al. 2009), systemic administration of cholinesterase inhibitors for augmenting cholinergic transmission,
improved both reversal learning (learning an association
exists between one stimulus (of a pair) and reward, to then
learn a reverse association where a previously unrewarded
stimulus is now rewarded) and attentional set-shifting (shifting from one mental set to another) impairments. Additional
experimental evidence emphasizes a role by prefrontal ACh
in cognitive flexibility, in particular the critical role by PFCmediated cholinergic signaling in the initial inhibition of a
previously learned strategy. Ridley et al. (1994) transplanted
neocortices of marmosets with cholinergic-rich neural tissue
some weeks after inducing bilateral excitotoxic lesions to the
NBM, where animals showed intact reversal learning during
a visual discrimination task. In addition, others showed no
impaired acquisition in an operant discrimination task, but
deficits in reversal learning, in rats that had received selective cholinergic lesioning of the NBMc (Cabrera et al. 2006).
However, the role of cholinergic signaling and the synergistic interaction between this neurochemical system and the
PFC in mediating cognitive flexibility remains controversial, with some authors reporting that ablation of basal forebrain cholinergic neurons does not impair reversal learning
(McGaughy et al. 2008; Tait and Brown 2008). Additional
participation in cognitive flexibility by ACh within other
brain areas such as the hippocampus, basolateral amygdala
and posterior parietal cortex also participate in cognitive
flexibility (Prado et al. 2017) may explain these controversies; however, the modulating role played by PFC ACh in
this process is strengthened by a large number of studies
showing that cholinergic depletion of different prefrontal
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areas results in dissociable deficits in separate forms of
cognitive flexibility. Optogenetic and chemogenetic tools
to modulate neuronal activity levels promise to characterize the cholinergic circuits involved this and other cognitive
domains and unravel the exact role of the PFC in the process.
Genetically modified rodents, including ChAT::Cre+ rats as
we assessed in the current study, compliment such cell- and
circuit-modifying tools, by allowing cholinergic machinery
to be spatially and temporally targeted. However, as our present study demonstrates, behavioral results obtained from
use of such animals should consider whether baseline behavioral changes are due to a hypercholinergic phenotype.
Cholinergic tone has also been associated with several
memory- and learning-related functions. In addition, cholinergic neurons of the PFC, which we dissected out in the
rats for gene and protein analysis of VAChT, have been
implicated as a modulator (via cholinergic signaling) of
specific aspects of memory (Croxson et al. 2011). Hence,
an important direction for future research is to characterize
the extent and nature of memory-related impairments in this
transgenic rat line.
Although the current work did not incorporate an extensive evaluation of memory-related functions in the rats, a
CFCT was included, where animals learn that certain environmental stimuli predict aversive events. This classical,
Pavlovian (respondent) conditioning model provides an
interface between memory and emotion (LeDoux 2000).
In this testing paradigm, we measured the frequency of a
defensive reflex namely freezing, shown by the rats during
the retention stage of the CFCT, with freezing response considered to provide a readout of memory that is dependent
on the hippocampus, amygdala and PFC (McEchron et al.
1998; Gilmartin and Helmstetter 2010; Kochli et al. 2015).
Hence, as this assessment entails cognitive/explicit and noncognitive/implicit fear memory that are supported by neural
pathways that converge, the CFCT rather assesses associative memory processes by testing a memory for the association between an aversive stimulus (mild foot shock) and a
salient environmental cue. Significantly enhanced freezing
behavior revealed upon re-presentation of the context by one
genotype rat group compared to the other would have indicated enhanced learning and memory ability. However, as
our results report no difference in the frequency of freezing
behavior, we conclude that this memory unit was unaffected
by the genotype of the rats.
Memory as a cognitive domain can be classified according to several criteria, including function (e.g., working vs.
reference memory), content (e.g. declarative/explicit vs.
procedural/implicit memory), duration (e.g., immediate or
short-term vs. long-term or remote memory), nature (associative vs. non-associative memory), or motivation (appetitive/reward vs. aversive memory). Hence, to allow for comprehensive profiling of mnemonic function, studies aimed at
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assessing differences in performance between ChAT::Cre+
versus ChAT::Cre+ rats should utilize a battery of tests that
cover most, if not all fundamental types of memory processes (Savage and Ma 2014).
With evidence suggesting that the HPA-axis may be dysfunctional in children with ADHD (Hong et al. 2003), and
intriguing findings indicating for a molecular interactive link
between the brain’s cholinergic systems and the HPA-axis
neuroendocrine system in modulating cognitive processes
(Paul et al. 2015), we also determined for possible defective
HPA-axis activity in ChAT::Cre+ compared to Wt siblings,
in response to fear conditioning. We assessed circulating
levels of HPA-axis activity markers. Specifically, the stress
hormone corticosterone, the main glucocorticoid in rodents
(Gong et al. 2015), leptin, a 16 kDa protein secreted by adipocytes, which has roles in controlling energy balance as
well as regulating responses to stress (Haleem 2014), and
glucose, since cortisol counters insulin by promoting higher
blood sugar and stimulating gluconeogenesis, for synthesizing glucose (Maniam et al. 2014). Biomarkers of HPA activity could not fully explain the effects observed in the transgenic rats. In the case of corticosterone, acute stress (foot
shock) induced increased plasma levels, but in both transgenic and Wt rats, to serve as a good biological validator of
the stress paradigm the rats were subjected to. Exposure to
the stressor did not alter levels of either leptin or glucose,
with levels of these markers of HPA activity that were also
independent of ChAT::Cre− genotype. It is possible that sex
differences may exist in both the endocrine, cognitive behavioral and stress responses shown by the ChAT::Cre+ rats as
a result of increased gene copies of VAChT, which translated
to overexpressed VAChT protein levels. Future work should
further investigate for such potential sex-specific differences.
The current work differentially analyzed VAChT protein
and mRNA levels between the transgenic ChAT::Cre+ and
non-transgenic ChAT::Cre− rats to PFC brain tissue samples. As a brain region that contains dense cholinergic innervation and outputs, the PFC was deemed to play multiple
functional roles that particularly relate to the cognitive processes that the battery of behavioral tests used in the present
study were designed for (Wallis 2007; Euston et al. 2012,
Funahashi 2013). This includes strong arguments that have
been made that ACh signaling in the PFC is strategically
uniquely positioned at both the start and terminal end of
the attentional loop (Sarter et al. 2001; Parikh et al. 2007).
Through a series of tests, we also undertook anxiety profiling in ChAT::Cre+ versus ChAT::Cre− rats. Again, several studies implicated the PFC in anxiety-related behavior,
with the PFC that was shown to exert integral control (via
cholinergic reciprocal connections) over the limbic system
(Kim and Whalen 2009). The strength of the connectivity
between the PFC and the amygdala has further been correlated with anxiety-like behavior shown in both the OF and
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EPM (Wei et al. 2010; Delpech et al. 2016). The OF and
EPM paradigms inherently also evaluate aspects of motor
control, including locomotion and explorative behavior. A
comprehensive body of literature implies an important role
for forebrain ACh in controlling these motor-related aspects,
as it exerts top-down control over several motor areas via
reciprocal connections with the PFC (Asaad et al. 2000;
Miller and Cohen 2001).
However, cholinergic neurotransmission throughout the
neocortex, but also the hippocampus, amygdala and PPN can
regulate arousal, learning and attention as well as aspects
of emotional processing (Inglis et al. 2000, 2001). Hence,
future work should aim to determine whether the presently
reported molecular findings pertaining to the PFC is specific
to this cholinergic brain region, or whether a similar VAChT
protein and mRNA level expression pattern is evident for
other brain regions containing cholinergic projection neurons in ChAT::Cre+ compared to ChAT::Cre− rats.
Taken together, the current results reveal that the
ChAT::Cre rat line overexpresses ‘extra’ copies of a gene
that functionally control cholinergic signaling. A similar
effect where the BAC transgene also introduces extra copies of adjacent genes to the genome is predicted to occur in
another popular transgenic rat line, namely TH::Cre+ rats
(Witten et al. 2011), with such rats expressing Cre recombinase in tyrosine hydroxylase (TH) neurons. As TH acts as
the rate-limiting enzyme of catecholamine biosynthesis, this
rat line has, therefore, been engineered to express Cre in catecholaminergic neurons, including dopaminergic ones, that
are affected progressively during neurodegenerative diseases
such as PD, and has, therefore, become particularly useful
for researching the pathological mechanisms concerning
PD. Hence, future efforts for developing novel transgenic
rat systems should utilize strategies for developing cleaner
transgenic lines by eliminating unwanted genes from modified BAC DNA that could complicate phenotypic analysis.
The increasing use of genetic models, which include
transgenic knockout and inbred strains of rodents has highlighted the importance of detailed characterization at behavioral and molecular-genetic levels of such rodents being used
for pursuing research questions. A milestone was reached
with the development of Cre/lox recombination techniques
to enable conditional gene targeting in rodents. The technology utilizes Cre recombinase that excises a gene segment
flanked by pairs of specific 34-bp DNA sequences termed
LoxP recognition sequences (McLellan et al. 2017). Use of
cell-specific drivers of Cre restricts recombination exclusively to cells where the driver gene is expressed, hence generating conditional knockout or knockin animals. However,
the desired tissue specificity may be difficult to apply using
Cre transgenic lines, with mosaic expression, leakiness of
the promoter, Cre-induced toxicity, or Cre non-specificity
that have been reported, all of which could confound the
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original purpose of the experiments. With this regard, several published reports have highlighted potential limitations
posed by the use of ChAT::Cre+ mouse lines in behavioral research (e.g., Crittenden et al. 2014; Chen et al. 2018).
Hence, our study provides evidence, for the first time, to
strongly suggest that caution should prevail when interpreting data derived from ChAT::Cre+ rats, for functionally
modulating cholinergic signaling, particularly in the utilization of cre/lox technology for evaluating the in vivo effects
of the ChAT gene on performance in cognitive tasks.
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